NCT01562067

Brief Summary

Cervical tumors are characterized by vascular changes (in terms of quantity, volume and Flows) in the tumor. Due to a good access to the cervix through the vagina, these parameters can be assessed using a three dimensional supersonic. Sonographic characteristics of tumor indices measures before and after oncological treatments may shed light on the patient's prognosis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2012

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2012

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

March 21, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 23, 2012

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2014

Completed
Last Updated

March 23, 2012

Status Verified

March 1, 2011

Enrollment Period

1.1 years

First QC Date

March 21, 2012

Last Update Submit

March 22, 2012

Conditions

Cancer

Keywords

Cervical tumors,vascular changes,Sonographic characteristics

Outcome Measures

Primary Outcomes (1)

  • Sonographic characteristics of cervical tumors

    Sonographic characteristics of cervical tumors indices measures before and after oncological treatments may shed light on the patient's prognosis.

    5 years

Interventions

ultrasound examinationDEVICE

ultrasound and doppler studies to evaluate size and vascularity of tumor during radiotherapy

Also known as: no other name

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

women with cervical cancer during radiotherapy

You may qualify if:

  • Cervical cancer patients intended to undergo chemotherapy or radiation, or both

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rambam Medical Center

Haifa, 30196, Israel

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

pap smear

MeSH Terms

Conditions

Neoplasms

Study Officials

  • amnon amit, md

    Rambam Health Care Campus

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 21, 2012

First Posted

March 23, 2012

Study Start

March 1, 2012

Primary Completion

April 1, 2013

Study Completion

April 1, 2014

Last Updated

March 23, 2012

Record last verified: 2011-03

Locations

IL(1)